PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hepatic & Biliary Function/Anti-LKM1
Hepatic & Biliary FunctionAutoimmune Hepatitis Type 2

Anti-LKM1 Antibodies (Anti-LKM1)

Autoantibodies targeting the 50-kDa cytochrome P450 2D6 (CYP2D6) enzyme located in the endoplasmic reticulum of hepatocytes and proximal renal tubules.

Standard Range<1:20 titer (negative)
Optimal LongevityNegative (<1:20)
Measurement UnitTiter
Organ SystemAutoimmune Hepatitis Type 2
Routine Panels:Pediatric Autoimmune Hepatitis Panel

Standard vs. Optimal Reference RangesTiter

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: Titer
Titer
Presets:
0 TiterOptimal Zone Target2 Titer
Optimal Longevity Zone(0.5 Titer)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<1:20 titer (negative)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

Negative (<1:20)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Mediates severe cytotoxic T-cell-driven destruction of hepatocytes, presenting acutely and aggressively in young children and adolescents.

Differential Diagnosis

Elevated Levels (Anti-LKM1 High)

  • •Type 2 Autoimmune Hepatitis (AIH-2, severe pediatric/adolescent onset)
  • •Chronic Hepatitis C infection (molecular mimicry in 5%)

Low Levels (Anti-LKM1 Low)

  • •Type 1 Autoimmune Hepatitis
  • •Healthy liver baseline

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Anti-LKM1 Antibodies (Anti-LKM1) plays an essential physiological role in autoimmune hepatitis type 2. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.
Longevity Risk Architecture & Epidemiology
Diagnostic hallmark for Type 2 Autoimmune Hepatitis (AIH-2), characterized by rapid progression to cirrhosis and subfulminant liver failure.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker quantification for Anti-LKM1
  • Targeted organ system imaging or functional dynamic testing related to autoimmune hepatitis type 2
  • Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Molecular Physiology of Anti-LKM1 Antibodies - The New England Journal of Medicine (2021). PMID: 34090124
  • [2]Anti-LKM1 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Common Panels:Pediatric Autoimmune Hepatitis Panel
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Anti-LKM1 Antibodies (Anti-LKM1) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hepatic & Biliary Function Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousAnti-Smooth Muscle Antibodies (ASMA)Hepatic & Biliary FunctionNextAntimitochondrial Antibodies (M2) (AMA-M2)Hepatic & Biliary Function